Report
Laura Roba

Agfa-Gevaert - Q3 23 results

Agfa published its Q3 23 results which were overall disappointing. The positive point is Healthcare IT showing an improvement in profitability with adj. EBIT coming in above CSS and DPe For the rest, revenues came in below CSS and estimates in all divisions, except DCP, which was in line. Profitability in Radiology came in well below CSS and DPe, with management expecting a weak performance in Q4. DPC is back to breakeven although still below CSS and expectations. The good news is that Zirfon started to contribute to profitability, although we do not know to what extent We will review
Underlying
Agfa-Gevaert NV

Agfa-Gevaert develops, produces and distributes various analog and digital imaging systems and IT solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. Co.'s operations can be divided into three business segments: Agfa Graphics, which provides integrated prepress products and services to the printing industry; Agfa HealthCare, which provides diagnostic imaging and healthcare IT products for hospitals and care centers around the world; and Agfa Specialty Products, which supplies a variety of film-based products to business- to-business customers outside the graphic and healthcare markets.

Provider
Degroof Petercam
Degroof Petercam

​We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

Analysts
Laura Roba

Other Reports on these Companies
Other Reports from Degroof Petercam

ResearchPool Subscriptions

Get the most out of your insights

Get in touch